Security key
72941H509
PLUS THERAPEUTICS, INC. - Common Stock, $0.001 par value per share (PSTV)
CUSIP: 72941H509
Q4 2024 13F Holders as of 31 Dec 2024
- Type / Class
- Equity / Common Stock, $0.001 par value per share
- Shares outstanding
- 183,877,102
- Total 13F shares
- 678,173
- Share change
- +6,523
- Total reported value
- $779,897
- Price per share
- $1.15
- Number of holders
- 10
- Value change
- +$3,467
- Number of buys
- 3
- Number of sells
- 2
Report period
Q4 2024
Institutions
10
Top holders
10
PSTV full security history
Newer quarter: Q1 2025
Previous quarter: Q3 2024
PLUS THERAPEUTICS, INC. SEC filings
PLUS THERAPEUTICS, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 72941H509
Recent filing periods:
Top shareholders of PSTV - PLUS THERAPEUTICS, INC. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| AIGH Capital Management LLC |
13F
|
Company |
0.31%
|
560,905
|
$818,921 | — | 30 Sep 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.03%
|
54,274
|
$79,239 | — | 30 Sep 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.02%
|
32,541
|
$47,510 | — | 30 Sep 2024 | |
| Ashton Thomas Private Wealth, LLC |
13F
|
Company |
0.01%
|
12,913
|
$18,853 | — | 30 Sep 2024 | |
| BlackRock, Inc. |
13F
|
Company |
0%
|
6,960
|
$10,162 | — | 30 Sep 2024 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
3,709
|
$5,415 | — | 30 Sep 2024 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
133
|
$194 | — | 30 Sep 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
100
|
$146 | — | 30 Sep 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
48
|
$70 | — | 30 Sep 2024 | |
| DANSKE BANK A/S |
13F
|
Company |
0%
|
1
|
$1 | — | 30 Sep 2024 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0%
|
1
|
$1 | — | 30 Sep 2024 | |
| Norman D. LaFrance |
3/4/5
|
Chief Medical Officer |
—
class O/S missing
|
24,073
|
— | — | 22 Feb 2024 |
Institutional Holders of PLUS THERAPEUTICS, INC. - Common Stock, $0.001 par value per share (PSTV) as of Q4 2024
As of 31 Dec 2024,
PLUS THERAPEUTICS, INC. - Common Stock, $0.001 par value per share (PSTV) was held by
10 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
678,173 shares.
The largest 10 holders included
AIGH Capital Management LLC, GEODE CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC, TWO SIGMA SECURITIES, LLC, BlackRock, Inc., Tower Research Capital LLC (TRC), OSAIC HOLDINGS, INC., SBI Securities Co., Ltd., BANK OF AMERICA CORP /DE/, and DANSKE BANK A/S.
This page lists
11
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
9
Q4 2024 holders
10
Holder diff
1
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 Value $ | Q4 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.